Latest filing published 25 Nov 2020 for GenMark Diagnostics, Inc., €36k. Read the official filing
All filings by Michael Gleeson on record concern GenMark Diagnostics, Inc. We count 81 filings; the first trade dates from 21 January 2016 and the latest from 24 November 2020.
Every open-market trade on record is a sale: 67 sales worth €1.4M. Besides market trades, the filings include 7 share grants and 6 option exercises. Since January 2020: no purchases and 10 sales on the market.
The record was last updated on 25 November 2020 with an open-market sale (€36k) in GenMark Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 81 declarations